Cargando…
The angiotensin II type 1 receptor blocker valsartan in the battle against COVID‐19
OBJECTIVE: Severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2) uses the host’s angiotensin‐converting enzyme 2 (ACE2) as a cellular entry point. Therefore, modulating ACE2 might impact SARS‐CoV‐2 viral replication, shedding, and coronavirus disease 2019 (COVID‐19) severity. Here, it was inv...
Autores principales: | de Ligt, Marlies, Hesselink, Matthijs K. C., Jorgensen, Johanna, Jocken, Johan W. E., Blaak, Ellen E., Goossens, Gijs H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242711/ https://www.ncbi.nlm.nih.gov/pubmed/33955183 http://dx.doi.org/10.1002/oby.23221 |
Ejemplares similares
-
Sporadic Case of Heterozygous X-Linked Alport Syndrome
por: Zuckerman, Jonathan E., et al.
Publicado: (2023) -
Perinatal Exposure to High-Fat Diet Programs Energy Balance, Metabolism and Behavior in Adulthood
por: Sullivan, Elinor L., et al.
Publicado: (2011) -
Using mobile sequencers in an academic classroom
por: Zaaijer, Sophie, et al.
Publicado: (2016) -
Cutting Edge: Failure of Antigen-Specific CD4(+) T Cell Recruitment to the Kidney during Systemic Candidiasis
por: Drummond, Rebecca A., et al.
Publicado: (2014) -
Cutting Edge: Circulating Plasmablasts Induce the Differentiation of Human T Follicular Helper Cells via IL-6 Production
por: Chavele, Konstantia-Maria, et al.
Publicado: (2015)